Overview

The Royal College of Pathologists is hosting the second of an annual workshop series in conjunction with the National Cancer Research Institute’s CM-Path initiative. This workshop will provide key information to pathologists who are keen to get involved in clinical research; to include an introduction to navigating the academic career pathway, quality assurance in clinical trials, statistics and clinical trial design.

We welcome trainees and established consultants with an interest in clinical research.

An excellent course. This is an important area and we need more events like this.   Workshop attendee, December 2016

Programme

09.30    Registration and Coffee

10.00    Getting into Clinical Trials: Tales of a Former Trainee Dr Nick West
10.30    Overview of NCRI Clinical Studies groups – experience of a CSG pathologist Dr Abeer Shaaban
10.45    Awareness of CSGs – Survey Results Dr Dennis Zhang

11.00    Coffee

Quality Assurance in Clinical Trials
11.15    Regulation and accreditation of laboratories undertaking trial work, Dr Owen Driskell
11.40    Scoring and reporting – guidance for laboratories undertaking trial work Dr Max Robinson
12.05    Use and validation of digital pathology and imaging for clinical trials and research  Professor Clare Verrill        
12.30    Panel discussion

13.00    Lunch & networking

14.15    NIHR Opportunities for Training. NIHR Costing for Trials – Where to Start? TBC
14.40    Trial Design and Statistics for Beginners Professor Judith Bliss  
15.10    CT-PAG: Providing Advice for Pathology in Clinical Trials Professor Craig Robson
    
15.40    Discussion and close 

Speakers

Speakers

  • Dr Dennis Zhang

    Dr Yu Zhi Zhang (Dennis) is currently an NIHR Clinical Research Fellow and PhD candidate based at National Heart and Lung Institute, Imperial College London. He was previously a Histopathology registrar and was trained at Imperial College Healthcare NHS Trust and St George’s Healthcare NHS Trust before undertaking an out-of-programme period for research. He joined CM-Path (Clinical Trials Workstream) in 2017 as a trainee member.

  • Dr Owen Driskell

    Dr Owen Driskell is a HCPC registered Clinical Biochemist and Lead for Laboratory Medicine for the NIHR Clinical Research Network West Midlands. His remit is to support professionalism in pathology research both in the services provided for NHS research and for pathology staff leading their own research, and to promote the contribution and importance of pathology services to the wider research community.

    He has worked in NHS pathology laboratories where one of his responsibilities has been the coordination of research activity for the whole pathology department. He has worked with the MHRA, HRA, NHS R&D forum, the NIHR CRN Coordinating Centre and others to promote the importance of engaging with pathology to support research and to develop training packages to address pathology research needs.

    Dr Driskell is also the founder of NIHR CRN West Midlands RAPID (Research Advisory group for Pathology In research Delivery), an NIHR Faculty Alumni, a member of the Association for Clinical Biochemistry and Laboratory Medicine's Scientific Committee and a Standing Member of the NICE Diagnostic Advisory Committee.

  • Professor Clare Verrill

    Professor Clare Verrill is an Associate Professor in Pathology in the Nuffield Dept of Surgical Sciences, University of Oxford and an Honorary Consultant in Cellular Pathology at the John Radcliffe Hospital where she is a urological pathology consultant, having achieved her CCT in 2008.

    Clare’s research interests are in, amongst other things, multi-modal and digital pathology and image analysis in cancer, primarily testis and prostate.  As well as her academic group (The Verrill Pathology Group)  Clare’s diverse roles include NIHR BRC 3 Sub-Theme lead for multimodal pathology,  CM-Path Workstream 4 Lead (Technology and Informatics), RCPath Thames Valley Regional College Advisor and a member of the NCRI Teenagers and Young Adults and Testis Clinical Studies Group.

    She is also Chair of the Oxford Digital Pathology Academic Forum – an academic group including pathologists, engineers and statisticians from which several novel collaborations have been developed and Chair of the Oxford Digital Pathology Working Group, which is an operational group, setting and implementing strategy around digital pathology and image analysis.

    Clare is co-lead for the Testis GeCIP (Clinical Interpretation Partnership) as part of the 100,000 Genomes Project and lead pathologist for a number of multisite clinical trials, including “PART – Partial Prostate Ablation Versus Radical Prostatectomy in Intermediate Risk Unilateral Clinically Localized Prostate Cancer” (PI Freddie Hamdy). 

Registration fees

RCPath Members: £194.00

Concessions: £104.00

Non RCPath Members: £270.00